David Fiellin, MD

Professor of Medicine (General Medicine), of Emergency Medicine, and of Public Health; Professor, Investigative Medicine; Director, Yale Program in Addiction Medicine; Director, Health Services and Research Core, Center for Interdisciplinary Research on AIDS (CIRA), School of Public Health

Research Departments & Organizations

Internal Medicine: General Internal Medicine: Program in Addiction Medicine; Yale Center for Health & Learning Games

School of Public Health: Center for Interdisciplinary Research on AIDS

Drug use, Addiction, and HIV Research Scholars (DAHRS)

Psychotherapy Development Center

SBIRT Training in Yale Residency Programs

Substance Abuse Research

Office of Cooperative Research

Research Interests

Acquired Immunodeficiency Syndrome; Alcoholism; Buprenorphine; Health Policy; HIV; Internal Medicine; Opioid-Related Disorders; Substance Abuse Detection; Substance Abuse Treatment Centers

Research Summary

Dr. Fiellin has focused his scholarly work on the interface between primary care and substance abuse. He conducts research on the transfer of treatment strategies, including opioid agonist treatment with buprenorphine and alcohol pharmacotherapies, from specialized settings to office-based, primary care, emergency department and HIV specialty settings.

Specialized Terms: Substance abuse treatment in primary care; Emergency department and HIV specialty settings opioid agonist treatment with buprenorphine; Pharmacologic treatment of alcohol

Selected Publications

See list of PubMed publications

Edit this profile